500
Participants
Start Date
October 13, 2015
Primary Completion Date
May 4, 2017
Study Completion Date
May 4, 2017
QVA149 110/50 micrograms
QVA149 110/50 micrograms o.d. capsules for inhalation, supplied in blisters via a single dose dry powder inhalater (SDDPI)
Salmeterol/fluticasone 50/500 microgrammes
Salmeterol/fluticasone 50/500 microgrammes b.i.d.dry inhalation powder delivered via Accuhaler / Diskus device
Novartis Investigative Site, Hazmiyeh
Novartis Investigative Site, Saida
Novartis Investigative Site, Manila
Novartis Investigative Site, Quezon City
Novartis Investigative Site, Drummoyne
Novartis Investigative Site, Westmead
Novartis Investigative Site, Johannesburg
Novartis Investigative Site, Coffs Harbour
Novartis Investigative Site, Bulacan
Novartis Investigative Site, San Pablo City, Laguna
Novartis Investigative Site, Durban
Novartis Investigative Site, Phoenix
Novartis Investigative Site, Lipa City
Novartis Investigative Site, Cairns
Novartis Investigative Site, Daw Park
Novartis Investigative Site, Bedford Park
Novartis Investigative Site, Glen Osmond
Novartis Investigative Site, Murdoch
Novartis Investigative Site, Beirut
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Gatesville
Novartis Investigative Site, Riyadh
Novartis Investigative Site, Cairo
Novartis Investigative Site, Sefad
Novartis Investigative Site, Kota Bharu
Novartis Investigative Site, Alexandria
Novartis Investigative Site, Jeddah
Novartis Investigative Site, New Taipei City
Novartis Investigative Site, Kuantan
Novartis Investigative Site, Erzurum
Novartis Investigative Site, Mersin
Novartis Investigative Site, Taiping
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Yenisehir/Izmir
Novartis Investigative Site, Taichung
Novartis Investigative Site, Konya
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Tel Giborim, Holon
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Trabzon
Novartis Investigative Site, Al Fayyum
Novartis Investigative Site, Ashkelon
Novartis Investigative Site, Kaoshiung
Novartis Investigative Site, Beersheba
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Kuching
Novartis Investigative Site, Miri
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Beirut
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Haifa
Novartis Investigative Site, Rehovot
Novartis Investigative Site, El Chouf
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Nagpur
Novartis Investigative Site, Mohali
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Beirut
Novartis Investigative Site, Linkou District
Novartis Investigative Site, Adana
Novartis Investigative Site, Aydin
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY